Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Shrinivas Kulkarni
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Living Beings
Concepts & Ideas
Activities & Behaviors
Disorders
Chemicals & Drugs
Physiology
Sign-in to see full Profile
Network (preview)
38
Dhir, Ashish
38
Naidu, Pattipati
28
Chopra, Kanwaljit
27
Patil, Chandrashekhar
22
Jain, Naveen
22
Singh, amanpreet
20
Singh, Vijay Pal
20
Bishnoi, Mahendra
15
Raghavendra, V
14
Ninan, Ipe
11
Reddy, DS
11
Akula, Kiran Kumar
8
Singh, Amarjit
7
sharma, sameer
6
Padi, Satyanarayana
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Shrinivas Kulkarni (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Gupta Amit; Dhir Ashish; Kumar Anil; Kulkarni S K
Protective effect of cyclooxygenase (COX)-inhibitors against drug-induced catatonia and MPTP-induced striatal lesions in rats.
Pharmacology, biochemistry, and behavior 2009;94(2):219-26.
-
2009: Akula K K; Dhir A; Kulkarni S K
Effect of various antiepileptic drugs in a pentylenetetrazol-induced seizure model in mice.
Methods and findings in experimental and clinical pharmacology 2009;31(7):423-32.
-
2009: Kulkarni Shrinivas K; Dhir Ashish
sigma-1 receptors in major depression and anxiety.
Expert review of neurotherapeutics 2009;9(7):1021-34.
-
2009: Kulkarni Shrinivas K; Dhir Ashish
Current investigational drugs for major depression.
Expert opinion on investigational drugs 2009;18(6):767-88.
-
2009: Bhutani Mohit Kumar; Bishnoi Mahendra; Kulkarni Shrinivas K
Anti-depressant like effect of curcumin and its combination with piperine in unpredictable chronic stress-induced behavioral, biochemical and neurochemical changes.
Pharmacology, biochemistry, and behavior 2009;92(1):39-43.
-
2009: Kulkarni Shrinivas K; Bishnoi Mahendra; Chopra Kanwaljit
In vivo microdialysis studies of striatal level of neurotransmitters after haloperidol and chlorpromazine administration.
Indian journal of experimental biology 2009;47(2):91-7.
-
2009: Kulkarni S K; Dhir Ashish
Cyclooxygenase in epilepsy: from perception to application.
Drugs of today (Barcelona, Spain : 1998) 2009;45(2):135-54.
-
2008: Dhir Ashish; Kulkarni S K
New therapeutic promises in the treatment of depression and schizophrenia.
Drug news & perspectives 2008;21(10):581-92.
-
2008: Padi Satyanarayana S V; Kulkarni Shrinivas K
Minocycline prevents the development of neuropathic pain, but not acute pain: possible anti-inflammatory and antioxidant mechanisms.
European journal of pharmacology 2008;601(1-3):79-87.
-
2008: Kulkarni Shrinivas K; Bhutani Mohit Kumar; Bishnoi Mahendra
Antidepressant activity of curcumin: involvement of serotonin and dopamine system.
Psychopharmacology 2008;201(3):435-42.
-
2008: Dhir Ashish; Kulkarni S K
Risperidone, an atypical antipsychotic enhances the antidepressant-like effect of venlafaxine or fluoxetine: possible involvement of alpha-2 adrenergic receptors.
Neuroscience letters 2008;445(1):83-8.
-
2008: Dhir Ashish; Kulkarni S K
Antidepressant-like effect of 17beta-estradiol: involvement of dopaminergic, serotonergic, and (or) sigma-1 receptor systems.
Canadian journal of physiology and pharmacology 2008;86(10):726-35.
-
2008: Akula Kiran Kumar; Kaur Manninder; Bishnoi Mahendra; Kulkarni Shrinivas K
Development and validation of an RP-HPLC method for the estimation of adenosine and related purines in brain tissues of rats.
Journal of separation science 2008;31(18):3139-47.
-
2008: Akula Kiran Kumar; Kaur Manninder; Kulkarni S K
Estimation of adenosine and its major metabolites in brain tissues of rats using high-performance thin-layer chromatography-densitometry.
Journal of chromatography. A 2008;1209(1-2):230-7.
-
2008: Kulkarni Shrinivas K; Singh Kulwinder; Bishnoi Mahendra
Comparative behavioural profile of newer antianxiety drugs on different mazes.
Indian journal of experimental biology 2008;46(9):633-8.
-
2008: Bishnoi Mahendra; Chopra Kanwaljit; Kulkarni Shrinivas K
Protective effect of L-type calcium channel blockers against haloperidol-induced orofacial dyskinesia: a behavioural, biochemical and neurochemical study.
Neurochemical research 2008;33(9):1869-80.
-
2008: Dhir Ashish; Kulkarni S K
Possible involvement of sigma-1 receptors in the anti-immobility action of bupropion, a dopamine reuptake inhibitor.
Fundamental & clinical pharmacology 2008;22(4):387-94.
-
2008: Bishnoi Mahendra; Chopra Kanwaljit; Kulkarni Shrinivas K
Activation of striatal inflammatory mediators and caspase-3 is central to haloperidol-induced orofacial dyskinesia.
European journal of pharmacology 2008;590(1-3):241-5.
-
2008: Bishnoi Mahendra; Chopra Kanwaljit; Kulkarni Shrinivas K
Differential striatal levels of TNF-alpha, NFkappaB p65 subunit and dopamine with chronic typical and atypical neuroleptic treatment: role in orofacial dyskinesia.
Progress in neuro-psychopharmacology & biological psychiatry 2008;32(6):1473-8.
-
2008: Kulkarni Shrinivas K; Dhir Ashish
On the mechanism of antidepressant-like action of berberine chloride.
European journal of pharmacology 2008;589(1-3):163-72.
-
2008: Kulkarni S K; Dhir Ashish
Withania somnifera: an Indian ginseng.
Progress in neuro-psychopharmacology & biological psychiatry 2008;32(5):1093-105.
-
2008: Kulkarni S K; Akula Kiran Kumar; Dhir Ashish
Effect of Withania somnifera Dunal root extract against pentylenetetrazol seizure threshold in mice: possible involvement of GABAergic system.
Indian journal of experimental biology 2008;46(6):465-9.
-
2008: Akula Kiran Kumar; Dhir Ashish; Kulkarni S K
Nitric oxide signaling pathway in the anti-convulsant effect of adenosine against pentylenetetrazol-induced seizure threshold in mice.
European journal of pharmacology 2008;587(1-3):129-34.
-
2008: Dhir Ashish; Kulkarni S K
Venlafaxine reverses chronic fatigue-induced behavioral, biochemical and neurochemical alterations in mice.
Pharmacology, biochemistry, and behavior 2008;89(4):563-71.
-
2008: Dhir A; Akula K K; Kulkarni S K
Rofecoxib potentiates the anticonvulsant effect of topiramate.
Inflammopharmacology 2008;16(2):83-6.
-
2008: Dhir Ashish; Akula Kiran Kumar; Kulkarni S K
Tiagabine, a GABA uptake inhibitor, attenuates 3-nitropropionic acid-induced alterations in various behavioral and biochemical parameters in rats.
Progress in neuro-psychopharmacology & biological psychiatry 2008;32(3):835-43.
-
2008: Dhir Ashish; Kulkarni S K
Possible involvement of nitric oxide (NO) signaling pathway in the antidepressant-like effect of MK-801(dizocilpine), a NMDA receptor antagonist in mouse forced swim test.
Indian journal of experimental biology 2008;46(3):164-70.
-
2008: Kulkarni S K; Singh V P
Positioning dual inhibitors in the treatment of pain and inflammatory disorders.
Inflammopharmacology 2008;16(1):1-15.
-
2008: Bishnoi Mahendra; Chopra Kanwaljit; Kulkarni Shrinivas K
Protective effect of Curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain.
Pharmacology, biochemistry, and behavior 2008;88(4):511-22.
-
2008: Bishnoi Mahendra; Chopra Kanwaljit; Kulkarni Shrinivas K
Progesterone attenuates neuroleptic-induced orofacial dyskinesia via the activity of its metabolite, allopregnanolone, a positive GABA(A) modulating neurosteroid.
Progress in neuro-psychopharmacology & biological psychiatry 2008;32(2):451-61.
-
2008: Bishnoi Mahendra; Chopra Kanwaljit; Kulkarni Shrinivas K
Modulatory effect of neurosteroids in haloperidol-induced vacuous chewing movements and related behaviors.
Psychopharmacology 2008;196(2):243-54.
-
2008: Kulkarni Shrinivas K; Singh Vijay P
Licofelone: the answer to unmet needs in osteoarthritis therapy?
Current rheumatology reports 2008;10(1):43-8.
-
2008: Akula Kiran Kumar; Dhir Ashish; Kulkarni S K
Rofecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor increases pentylenetetrazol seizure threshold in mice: possible involvement of adenosinergic mechanism.
Epilepsy research 2008;78(1):60-70.
-
2007: Akula Kiran Kumar; Dhir Ashish; Kulkarni S K
Systemic administration of adenosine ameliorates pentylenetetrazol-induced chemical kindling and secondary behavioural and biochemical changes in mice.
Fundamental & clinical pharmacology 2007;21(6):583-94.
-
2007: Dhir Ashish; Naidu Pattipati S; Kulkarni Shrinivas K
Neuroprotective effect of nimesulide, a preferential COX-2 inhibitor, against pentylenetetrazol (PTZ)-induced chemical kindling and associated biochemical parameters in mice.
Seizure : the journal of the British Epilepsy Association 2007;16(8):691-7.
-
2007: Bishnoi M; Chopra K; Kulkarni S K
U-74500A (lazaroid), a 21-aminosteroid attenuates neuroleptic-induced orofacial dyskinesia.
Methods and findings in experimental and clinical pharmacology 2007;29(9):601-5.
-
2007: Bishnoi Mahendra; Chopra Kanwaljit; Kulkarni Shrinivas K
Protective effect of rutin, a polyphenolic flavonoid against haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes.
Fundamental & clinical pharmacology 2007;21(5):521-9.
-
2007: Akula Kiran Kumar; Dhir Ashish; Bishnoi Mahendra; Kulkarni S K
Effect of systemic administration of adenosine on brain adenosine levels in pentylenetetrazol-induced seizure threshold in mice.
Neuroscience letters 2007;425(1):39-42.
-
2007: Dhir Ashish; Kulkarni S K
Involvement of dopamine (DA)/serotonin (5-HT)/sigma (sigma) receptor modulation in mediating the antidepressant action of ropinirole hydrochloride, a D2/D3 dopamine receptor agonist.
Brain research bulletin 2007;74(1-3):58-65.
-
2007: Akula Kiran Kumar; Dhir Ashish; Kulkarni S K
Pro-convulsant effect of cefazolin sodium against pentylenetetrazol- or picrotoxin-induced convulsions in mice.
Indian journal of experimental biology 2007;45(8):720-5.
-
2007: Kulkarni Shrinivas K; Dhir Ashish
Possible involvement of L-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling pathway in the antidepressant activity of berberine chloride.
European journal of pharmacology 2007;569(1-2):77-83.
-
2007: Kulkarni S K; Dhir Ashish
Effect of various classes of antidepressants in behavioral paradigms of despair.
Progress in neuro-psychopharmacology & biological psychiatry 2007;31(6):1248-54.
-
2007: Kulkarni S K; Kaushal Anupama; Dhir Ashish
Effect of withdrawal of diazepam or morphine treatment on gastric motility (charcoal meal test) in mice: possible role of different central and peripheral receptors.
Indian journal of experimental biology 2007;45(7):642-8.
-
2007: Dhir Ashish; Kulkarni S K
Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor.
European journal of pharmacology 2007;568(1-3):177-85.
-
2007: Kulkarni S K; Singh K; Bishnoi M
Elevated zero maze: a paradigm to evaluate antianxiety effects of drugs.
Methods and findings in experimental and clinical pharmacology 2007;29(5):343-8.
-
2007: Dhir Ashish; Kulkarni S K
Involvement of sigma-1 receptor modulation in the antidepressant action of venlafaxine.
Neuroscience letters 2007;420(3):204-8.
-
2007: Bishnoi Mahendra; Chopra Kanwaljit; Kulkarni Shrinivas K
Possible anti-oxidant and neuroprotective mechanisms of zolpidem in attenuating typical anti-psychotic-induced orofacial dyskinesia: a biochemical and neurochemical study.
Progress in neuro-psychopharmacology & biological psychiatry 2007;31(5):1130-8.
-
2007: Kulkarni Shrinivas K; Singh Kulwinder; Bishnoi Mahendra
Involvement of adenosinergic receptors in anxiety related behaviours.
Indian journal of experimental biology 2007;45(5):439-43.
-
2007: Dhir Ashish; Kulkarni S K
Involvement of L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of venlafaxine in mice.
Progress in neuro-psychopharmacology & biological psychiatry 2007;31(4):921-5.
-
2007: Bishnoi M; Chopra K; Kulkarni S K
Neurochemical changes associated with chronic administration of typical antipsychotics and its relationship with tardive dyskinesia.
Methods and findings in experimental and clinical pharmacology 2007;29(3):211-6.
-
2007: Bishnoi Mahendra; Chopra Kanwaljit; Kulkarni Shrinivas K
Theophylline, adenosine receptor antagonist prevents behavioral, biochemical and neurochemical changes associated with an animal model of tardive dyskinesia.
Pharmacological reports : PR 2007;59(2):181-91.
-
2007: Sharma Sameer; Chopra Kanwaljit; Kulkarni Shrinivas K
Effect of insulin and its combination with resveratrol or curcumin in attenuation of diabetic neuropathic pain: participation of nitric oxide and TNF-alpha.
Phytotherapy research : PTR 2007;21(3):278-83.
-
2007: Bishnoi Mahendra; Kumar Anil; Chopra Kanwaljit; Kulkarni Shrinivas K
Comparative neurochemical changes associated with chronic administration of typical and atypical neuroleptics: implications in tardive dyskinesia.
Indian journal of experimental biology 2007;45(2):175-9.
-
2007: Sharma Sameer; Kulkarni Shrinivas K; Chopra Kanwaljit
Effect of resveratrol, a polyphenolic phytoalexin, on thermal hyperalgesia in a mouse model of diabetic neuropathic pain.
Fundamental & clinical pharmacology 2007;21(1):89-94.
-
2007: Sharma S; Chopra K; Kulkarni S K; Agrewala J N
Resveratrol and curcumin suppress immune response through CD28/CTLA-4 and CD80 co-stimulatory pathway.
Clinical and experimental immunology 2007;147(1):155-63.
-
2007: Dhir Ashish; Kulkarni S K
Effect of addition of yohimbine (alpha-2-receptor antagonist) to the antidepressant activity of fluoxetine or venlafaxine in the mouse forced swim test.
Pharmacology 2007;80(4):239-43.
-
2007: Bishnoi Mahendra; Chopra Kanwaljit; Kulkarni Shrinivas K
Protective effect of adenosine reuptake inhibitors in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes.
Pharmacology 2007;79(3):171-83.
-
2007: Kulkarni S K; Singh Vijay Pal
Licofelone--a novel analgesic and anti-inflammatory agent.
Current topics in medicinal chemistry 2007;7(3):251-63.
-
2007: Bishnoi Mahendra; Patil C S; Kumar Anil; Kulkarni Shrinivas K
Co-administration of acetyl-11-keto-beta-boswellic acid, a specific 5-lipoxygenase inhibitor, potentiates the protective effect of COX-2 inhibitors in kainic acid-induced neurotoxicity in mice.
Pharmacology 2007;79(1):34-41.
-
2006: Dhir A; Kulkarni S K
Rofecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor potentiates the anticonvulsant activity of tiagabine against pentylenetetrazol-induced convulsions in mice.
Inflammopharmacology 2006;14(5-6):222-5.
-
2006: Bishnoi Mahendra; Chopra Kanwaljit; Kulkarni Shrinivas K
Involvement of adenosinergic receptor system in an animal model of tardive dyskinesia and associated behavioural, biochemical and neurochemical changes.
European journal of pharmacology 2006;552(1-3):55-66.
-
2006: Dhir Ashish; Naidu Pattipati S; Kulkarni Shrinivas K
Effect of cyclooxygenase inhibitors on pentylenetetrazol (PTZ)-induced convulsions: Possible mechanism of action.
Progress in neuro-psychopharmacology & biological psychiatry 2006;30(8):1478-85.
-
2006: Sharma Sameer; Kulkarni Shrinivas K; Chopra Kanwaljit
Curcumin, the active principle of turmeric (Curcuma longa), ameliorates diabetic nephropathy in rats.
Clinical and experimental pharmacology & physiology 2006;33(10):940-5.
-
2006: Sharma Sameer; Kulkarni S K; Chopra Kanwaljit
Resveratrol, a polyphenolic phytoalexin attenuates thermal hyperalgesia and cold allodynia in STZ-induced diabetic rats.
Indian journal of experimental biology 2006;44(7):566-9.
-
2006: Kumar Anil; Kulkarni S K
Protective effect of BR-16A, a polyherbal preparation against social isolation stress: possible GABAergic mechanism.
Phytotherapy research : PTR 2006;20(7):538-41.
-
2006: Dhir Ashish; Naidu Pattipati S; Kulkarni Shrinivas K
Effect of rofecoxib, a cyclo-oxygenase-2 inhibitor, on various biochemical parameters of brain associated with pentylenetetrazol-induced chemical kindling in mice.
Fundamental & clinical pharmacology 2006;20(3):255-61.
-
2006: Patil Chandrashekhar S; Singh Vijay Pal; Kulkarni Shrinivas K
Modulatory effect of sildenafil in diabetes and electroconvulsive shock-induced cognitive dysfunction in rats.
Pharmacological reports : PR 2006;58(3):373-80.
-
2006: Dhir Ashish; Naidu Pattipati S; Kulkarni Shrinivas K
Effect of cyclooxygenase-2 (COX-2) inhibitors in various animal models (bicuculline, picrotoxin, maximal electroshock-induced convulsions) of epilepsy with possible mechanism of action.
Indian journal of experimental biology 2006;44(4):286-91.
-
2006: Padi S S V; Naidu P S; Kulkarni S K
Involvement of peripheral prostaglandins in formalin-induced nociceptive behaviours in the orofacial area of rats.
Inflammopharmacology 2006;14(1-2):57-61.
-
2006: Dhir Ashish; Padi Satyanarayana S V; Naidu Pattipati S; Kulkarni Shrinivas K
Protective effect of naproxen (non-selective COX-inhibitor) or rofecoxib (selective COX-2 inhibitor) on immobilization stress-induced behavioral and biochemical alterations in mice.
European journal of pharmacology 2006;535(1-3):192-8.
-
2006: Bishnoi Mahendra; Patil Chandrashekar S; Kumar Anil; Kulkarni Shrinivas K
Potentiation of antinociceptive effect of NSAIDs by a specific lipooxygenase inhibitor, acetyl 11-keto-beta boswellic acid.
Indian journal of experimental biology 2006;44(2):128-32.
-
2006: Singh Vijay Pal; Patil Chandrashekhar S; Kulkarni Shrinivas K
Anti-inflammatory effect of licofelone against various inflammatory challenges.
Fundamental & clinical pharmacology 2006;20(1):65-71.
-
2006: Naidu Pattipati S; Singh Amanpreet; Kulkarni Shrinivas K
Effect of Withania somnifera root extract on reserpine-induced orofacial dyskinesia and cognitive dysfunction.
Phytotherapy research : PTR 2006;20(2):140-6.
-
2006: Singh Vijay Pal; Patil Chandrashekhar S; Kulkarni Shrinivas K
Analysis of interaction between etoricoxib and tramadol against mechanical hyperalgesia of spinal cord injury in rats.
Life sciences 2006;78(11):1168-74.
-
2006: Kumar Anil; Kulkarni S K
Effect of BR-16A (Mentat), a polyherbal formulation on drug-induced catalepsy in mice.
Indian journal of experimental biology 2006;44(1):45-8.
-
2006: Deshpande Chandrashekhar; Dhir Ashish; Kulkarni S K
Antagonistic activity of ascorbic acid (vitamin C) on dopaminergic modulation: apomorphine-induced stereotypic behavior in mice.
Pharmacology 2006;77(1):38-45.
-
2006: Sharma Sameer; Anjaneyulu Muragundla; Kulkarni S K; Chopra Kanwaljit
Resveratrol, a polyphenolic phytoalexin, attenuates diabetic nephropathy in rats.
Pharmacology 2006;76(2):69-75.
-
2005: Singh Vijay Pal; Patil Chandrashekhar S; Kumar Manish; Kulkarni Shrinivas K
Effect of 5-lipoxygenase inhibitor against lipopolysaccharide-induced hypothermia in mice.
Indian journal of experimental biology 2005;43(12):1150-5.
-
2005: Dhir Ashish; Naidu Pattipati S; Kulkarni Shrinivas K
Protective effect of cyclooxygenase-2 (COX-2) inhibitors but not non-selective cyclooxygenase (COX)-inhibitors on ethanol withdrawal-induced behavioural changes.
Addiction biology 2005;10(4):329-35.
-
2005: Joshi Dipesh; Naidu Pattipati S; Singh Amanpreet; Kulkarni Shrinivas K
Reversal of triazolam tolerance and withdrawal-induced hyperlocomotor activity and anxiety by bupropion in mice.
Pharmacology 2005;75(2):93-7.
-
2005: Bishnoi M; Patil C S; Kumar A; Kulkarni S K
Protective effects of nimesulide (COX Inhibitor), AKBA (5-LOX Inhibitor), and their combination in aging-associated abnormalities in mice.
Methods and findings in experimental and clinical pharmacology 2005;27(7):465-70.
-
2005: Dhir Ashish; Naidu Pattipati S; Kulkarni Shrinivas K
Effect of naproxen, a non-selective cyclo-oxygenase inhibitor, on pentylenetetrazol-induced kindling in mice.
Clinical and experimental pharmacology & physiology 2005;32(7):574-84.
-
2005: Singh Vijay Pal; Patil Chandrashekhar S; Kulkarni Shrinivas K
Differential effect of zileuton, a 5-lipoxygenase inhibitor, against nociceptive paradigms in mice and rats.
Pharmacology, biochemistry, and behavior 2005;81(3):433-9.
-
2005: Sharma Sameer; Jain N K; Kulkarni S K
Possible analgesic and anti-inflammatory interactions of aspartame with opioids and NSAIDs.
Indian journal of experimental biology 2005;43(6):498-502.
-
2005: Singh Vijay P; Patil Chandrashekhar S; Kulkarni Shrinivas K
Effect of licofelone against mechanical hyperalgesia and cold allodynia in the rat model of incisional pain.
Pharmacological reports : PR 2005;57(3):380-4.
-
2005: Goel R K; Thind J S; Bal C S; Mahajan M P; Kulkarni S K
Hypocholesterolemic activity of some novel azetidin-2-ones in diet and diabetes induced hypercholesterolemia in rats.
Die Pharmazie 2005;60(5):369-74.
-
2005: Singh Vijay Pal; Patil Chandrashekhar S; Kulkarni Shrinivas K
Effect of licofelone against NSAIDs-induced gastrointestinal ulceration and inflammation.
Indian journal of experimental biology 2005;43(3):247-53.
-
2005: Manáková Sárka; Singh Amanpreet; Kääriäinen Tiina; Taari Heli; Kulkarni Shrinivas K; Männistö Pekka T
Failure of FK506 (tacrolimus) to alleviate apomorphine-induced circling in rat Parkinson model in spite of some cytoprotective effects in SH-SY5Y dopaminergic cells.
Brain research 2005;1038(1):83-91.
-
2005: Patil Chandrashekhar S; Singh Vijay Pal; Jain Naveen K; Kulkarni Shrinivas K
Inhibitory effect of sildenafil on gastrointestinal smooth muscle: role of NO-cGMP transduction pathway.
Indian journal of experimental biology 2005;43(2):167-71.
-
2005: Padi Satyanarayana S V; Kulkarni Shrinivas K
Role of cyclooxygenase-2 in lipopolysaccharide-induced hyperalgesia in formalin test.
Indian journal of experimental biology 2005;43(1):53-60.
-
2005: Patil Chandrashekhar S; Singh Vijay Pal; Kulkarni Shrinivas K
Peripheral and central activation of nitric oxide-cyclic GMP pathway by sildenafil.
Inflammopharmacology 2005;13(5-6):467-78.
-
2005: Joshi D; Naidu P S; Singh A; Kulkarni S K
Protective effect of quercetin on alcohol abstinence-induced anxiety and convulsions.
Journal of medicinal food 2005;8(3):392-6.
-
2005: Goel Rajesh K; Singh Amanpreet; Naidu Pattipati S; Mahajan Mohinder P; Kulkarni Shrinivas K
PASS assisted search and evaluation of some azetidin-2-ones as C.N.S. active agents.
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Société canadienne des sciences pharmaceutiques 2005;8(2):182-9.
-
2004: Kulkarni S K; Patil C S
Phosphodiesterase 5 enzyme and its inhibitors: update on pharmacological and therapeutical aspects.
Methods and findings in experimental and clinical pharmacology 2004;26(10):789-99.
-
2004: Patil Chandrashekhar S; Singh Vijay Pal; Singh Sukhjeet; Kulkarni Shrinivas K
Modulatory effect of the PDE-5 inhibitor sildenafil in diabetic neuropathy.
Pharmacology 2004;72(3):190-5.
-
2004: Joshi D; Singh A; Naidu P S; Kulkarni S K
Protective effect of bupropion on morphine tolerance and dependence in mice.
Methods and findings in experimental and clinical pharmacology 2004;26(8):623-6.
-
2004: Padi Satyanarayana S V; Kulkarni Shrinivas K
Differential effects of naproxen and rofecoxib on the development of hypersensitivity following nerve injury in rats.
Pharmacology, biochemistry, and behavior 2004;79(2):349-58.
-
2004: Singh Vijay Pal; Patil Chandrashekhar S; Jain Naveen K; Kulkarni Shrinivas K
Aggravation of inflammatory bowel disease by cyclooxygenase-2 inhibitors in rats.
Pharmacology 2004;72(2):77-84.
-
2004: Singh Vijay Pal; Patil Chandrashekhar S; Kulkarni Shrinivas K
Effect of 5-lipoxygenase inhibition on events associated with inflammatory bowel disease in rats.
Indian journal of experimental biology 2004;42(7):667-73.
-
2004: Satyanarayana Padi S V; Jain Naveen K; Singh Amarjit; Kulkarni Shrinivas K
Isobolographic analysis of interaction between cyclooxygenase inhibitors and tramadol in acetic acid-induced writhing in mice.
Progress in neuro-psychopharmacology & biological psychiatry 2004;28(4):641-9.
-
2004: Naidu P S; Kulkarni S K
Quercetin, a bioflavonoid, reverses haloperidol-induced catalepsy.
Methods and findings in experimental and clinical pharmacology 2004;26(5):323-6.
-
2004: Kulkarni Shrinivas K; Patil Chandrashekhar S; Jain Naveen K; Singh Amarjit
Modulatory effect of diclofenac on antispasmodic effect of pitofenone in cholinergic spasm.
Indian journal of experimental biology 2004;42(6):567-9.
-
2004: Kumar Anil; Kulkarni S K
On the sleep promoting effects of BR-16A: interaction with GABAergic modulators.
Indian journal of experimental biology 2004;42(5):448-51.
-
2004: Goel Rajesh K; Mahajan Mohinder P; Kulkarni Shrinivas K
Evaluation of anti-hyperglycemic activity of some novel monocyclic beta lactams.
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Société canadienne des sciences pharmaceutiques 2004;7(1):80-3.
-
2004: Padi Satyanarayana S V; Jain Naveen K; Singh Sukhjeet; Kulkarni Shrinivas K
Pharmacological profile of parecoxib: a novel, potent injectable selective cyclooxygenase-2 inhibitor.
European journal of pharmacology 2004;491(1):69-76.
-
2004: Patil Chandrashekhar S; Jain Naveen K; Singh Vijay Pal; Kulkarni Shrinivas K
Cholinergic-NO-cGMP mediation of sildenafil-induced antinociception.
Indian journal of experimental biology 2004;42(4):361-7.
-
2004: Naidu Pattipati S; Singh Amanpreet; Kulkarni Shrinivas K
Reversal of reserpine-induced orofacial dyskinesia and cognitive dysfunction by quercetin.
Pharmacology 2004;70(2):59-67.
-
2004: Singh Vijay Pal; Patil Chandrashekhar S; Kulkarni Shrinivas K
Effect of zileuton in radicular pain induced by herniated nucleus pulposus in rats.
Inflammopharmacology 2004;12(2):189-95.
-
2004: Satyanarayana Padi S V; Jain Naveen K; Singh Sukhjeet; Kulkarni Shrinivas K
Effect of selective inhibition of cyclooxygenase-2 on lipopolysaccharide-induced hyperalgesia.
Inflammopharmacology 2004;12(1):57-68.
-
2003: Singh Amanpreet; Kumar Gaurav; Naidu Pattipati S; Kulkarni Shrinivas K
Antinociceptive action of FK506 in mice.
Indian journal of experimental biology 2003;41(12):1405-9.
-
2003: Naidu Pattipati S; Singh Amanpreet; Kulkarni Shrinivas K
D2-dopamine receptor and alpha2-adrenoreceptor-mediated analgesic response of quercetin.
Indian journal of experimental biology 2003;41(12):1400-4.
-
2003: Patil Chandrashekhar S; Jain Naveen K; Singh Amarjit; Kulkarni Shrinivas K
Modulatory effect of cyclooxygenase inhibitors on sildenafil-induced antinociception.
Pharmacology 2003;69(4):183-9.
-
2003: Singh Amanpreet; Naidu Pattipati S; Kulkarni Shrinivas K
FK506 as effective adjunct to L-dopa in reserpine-induced catalepsy in rats.
Indian journal of experimental biology 2003;41(11):1264-8.
-
2003: Singh Amanpreet; Naidu Pattipati S; Kulkarni Shrinivas K
Reversal of aging and chronic ethanol-induced cognitive dysfunction by quercetin a bioflavonoid.
Free radical research 2003;37(11):1245-52.
-
2003: Singh Vijay Pal; Patil Chandrashekhar S; Jain Naveen K; Singh Amarjit; Kulkarni Shrinivas K
Paradoxical effects of opioid antagonist naloxone on SSRI-induced analgesia and tolerance in mice.
Pharmacology 2003;69(3):115-22.
-
2003: Patil Chandrashekhar S; Singh Vijay Pal; Satyanarayan P S V; Jain Naveen K; Singh Amarjit; Kulkarni Shrinivas K
Protective effect of flavonoids against aging- and lipopolysaccharide-induced cognitive impairment in mice.
Pharmacology 2003;69(2):59-67.
-
2003: Singh Amanpreet; Naidu Pattipati S; Kulkarni Shrinivas K
Possible antioxidant and neuroprotective mechanisms of FK506 in attenuating haloperidol-induced orofacial dyskinesia.
European journal of pharmacology 2003;477(2):87-94.
-
2003: Naidu Pattipati S; Singh Amanpreet; Joshi Dipesh; Kulkarni Shrinivas K
Possible mechanisms of action in quercetin reversal of morphine tolerance and dependence.
Addiction biology 2003;8(3):327-36.
-
2003: Singh Vijay Pal; Patil Chandrashekhar S; Jain Naveen K; Singh Amarjit; Kulkarni Shrinivas K
Effect of nimesulide on acetic acid- and leukotriene-induced inflammatory bowel disease in rats.
Prostaglandins & other lipid mediators 2003;71(3-4):163-75.
-
2003: Singh Amanpreet; Kumar Gaurav; Naidu Pattipati S; Kulkarni Shrinivas K
Protective effect of FK506 (tacrolimus) in pentylenetetrazol-induced kindling in mice.
Pharmacology, biochemistry, and behavior 2003;75(4):853-60.
-
2003: Naidu Pattipati S; Singh Amanpreet; Kulkarni Shrinivas K
Quercetin, a bioflavonoid, attenuates haloperidol-induced orofacial dyskinesia.
Neuropharmacology 2003;44(8):1100-6.
-
2003: Singh Amanpreet; Naidu Pattipati S; Kulkarni Shrinivas K
Quercetin potentiates L-Dopa reversal of drug-induced catalepsy in rats: possible COMT/MAO inhibition.
Pharmacology 2003;68(2):81-8.
-
2003: Naidu Pattipati S; Singh Amanpreet; Kulkarni Shrinivas K
Reversal of haloperidol-induced orofacial dyskinesia by quercetin, a bioflavonoid.
Psychopharmacology 2003;167(4):418-23.
-
2003: Singh V P; Jain N K; Kulkarni S K
Fluoxetine suppresses morphine tolerance and dependence: modulation of NO-cGMP/DA/serotoninergic pathways.
Methods and findings in experimental and clinical pharmacology 2003;25(4):273-80.
-
2003: Jain Naveen K; Patil C S; Singh Amarjit; Kulkarni Shrinivas K
Sildenafil, a phosphodiesterase-5 inhibitor, enhances the antinociceptive effect of morphine.
Pharmacology 2003;67(3):150-6.
-
2003: Naidu Pattipati S; Singh Amanpreet; Kaur Pushpinder; Sandhir Rajat; Kulkarni Shrinivas K
Possible mechanism of action in melatonin attenuation of haloperidol-induced orofacial dyskinesia.
Pharmacology, biochemistry, and behavior 2003;74(3):641-8.
-
2003: Kaur G; Kulkarni S K
Involvement of normal physiological mechanisms in mediation of satiety by polyherbal antiobesity preparation, OB-200G, in female mice.
Methods and findings in experimental and clinical pharmacology 2003;25(1):33-9.
-
2003: Kulkarni Shrinivas K; Naidu Pattipati S
Pathophysiology and drug therapy of tardive dyskinesia: current concepts and future perspectives.
Drugs of today (Barcelona, Spain : 1998) 2003;39(1):19-49.
-
2003: Singh Amanpreet; Naidu Pattipati S; Patil C S; Kulkarni Shrinivas K
Effect of FK506 (tacrolimus) in animal models of inflammation.
Inflammopharmacology 2003;11(3):249-57.
-
2003: Naidu Pattipati S; Singh Amanpreet; Kulkarni Shrinivas K
Effect of Withania somnifera root extract on haloperidol-induced orofacial dyskinesia: possible mechanisms of action.
Journal of medicinal food 2003;6(2):107-14.
-
2002: Paul V N; Chopra K; Kulkarni S K
Histaminergic modulation of stress-induced analgesia and cognitive dysfunction.
Methods and findings in experimental and clinical pharmacology 2002;24(7):413-9.
-
2002: Singh Amanpreet; Kulkarni S K
Role of adenosine in drug-induced catatonia in mice.
Indian journal of experimental biology 2002;40(8):882-8.
-
2002: Jain Naveen K; Patil C S; Kulkarni Shrinivas K; Singh Amarjit
Modulatory role of cyclooxygenase inhibitors in aging- and scopolamine or lipopolysaccharide-induced cognitive dysfunction in mice.
Behavioural brain research 2002;133(2):369-76.
-
2002: Kaur Gurpreet; Kulkarni Shrinivas K
Evidence for serotonergic modulation of progesterone-induced hyperphagia, depression and algesia in female mice.
Brain research 2002;943(2):206-15.
-
2002: Naidu Pattipati S; Kulkarni Shrinivas K
Differential effects of cyclooxygenase inhibitors on haloperidol-induced catalepsy.
Progress in neuro-psychopharmacology & biological psychiatry 2002;26(5):819-22.
-
2002: Jain Naveen K; Kulkarni Shrinivas K; Singh Amarjit
Modulation of NSAID-induced antinociceptive and anti-inflammatory effects by alpha2-adrenoceptor agonists with gastroprotective effects.
Life sciences 2002;70(24):2857-69.
-
2002: Naidu Pattipati S; Singh Amanpreet; Kulkarni Shrinivas K
Carvedilol attenuates neuroleptic-induced orofacial dyskinesia: possible antioxidant mechanisms.
British journal of pharmacology 2002;136(2):193-200.
-
2002: Kaur Gurpreet; Kulkarni Shrinivas K
Studies on modulation of feeding behavior by atypical antipsychotics in female mice.
Progress in neuro-psychopharmacology & biological psychiatry 2002;26(2):277-85.
-
2002: Singh A; Kulkarni S K
Nitecapone and selegiline as effective adjuncts to L-DOPA in reserpine-induced catatonia in mice.
Methods and findings in experimental and clinical pharmacology 2002;24(1):23-9.
-
2002: Singh Amanpreet; Naidu Pattipati S; Gupta Saraswati; Kulkarni Shrinivas K
Effect of natural and synthetic antioxidants in a mouse model of chronic fatigue syndrome.
Journal of medicinal food 2002;5(4):211-20.
-
2001: Jain N K; Kulkarni S K; Singh A
Lipopolysaccharide-mediated immobility in mice: reversal by cyclooxygenase enzyme inhibitors.
Methods and findings in experimental and clinical pharmacology 2001;23(8):441-4.
-
2001: Singh V P; Jain N K; Kulkarni S K
On the antinociceptive effect of fluoxetine, a selective serotonin reuptake inhibitor.
Brain research 2001;915(2):218-26.
-
2001: Naidu P S; Kulkarni S K
Effect of 5-HT1A and 5-HT2A/2C receptor modulation on neuroleptic-induced vacuous chewing movements.
European journal of pharmacology 2001;428(1):81-6.
-
2001: Jain N K; Patil C S; Singh A; Kulkarni S K
Sildenafil-induced peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway.
Brain research 2001;909(1-2):170-8.
-
2001: Kaur G; Kulkarni S K
Differential effect of polyherbal, antiobesity preparation, OB-200G in male and female mice and monosodium glutamate-treated rats.
Indian journal of experimental biology 2001;39(6):551-7.
-
2001: Raghavendra V; Naidu P S; Kulkarni S K
Reversal of reserpine-induced vacuous chewing movements in rats by melatonin: involvement of peripheral benzodiazepine receptors.
Brain research 2001;904(1):149-52.
-
2001: Naidu P S; Kulkarni S K
Excitatory mechanisms in neuroleptic-induced vacuous chewing movements (VCMs): possible involvement of calcium and nitric oxide.
Behavioural pharmacology 2001;12(3):209-16.
-
2001: Raghavendra V; Singh V; Shaji A V; Vohra H; Kulkarni S K; Agrewala J N
Melatonin provides signal 3 to unprimed CD4(+) T cells but failed to stimulate LPS primed B cells.
Clinical and experimental immunology 2001;124(3):414-22.
-
2001: Jain N K; Kulkarni S K; Singh A
Role of cysteinyl leukotrienes in nociceptive and inflammatory conditions in experimental animals.
European journal of pharmacology 2001;423(1):85-92.
-
2001: Raghavendra V; Singh V; Kulkarni S K; Agrewala J N
Melatonin enhances Th2 cell mediated immune responses: lack of sensitivity to reversal by naltrexone or benzodiazepine receptor antagonists.
Molecular and cellular biochemistry 2001;221(1-2):57-62.
-
2001: Naidu P S; Kulkarni S K
Reversal of neuroleptic-induced orofacial dyskinesia by 5-HT3 receptor antagonists.
European journal of pharmacology 2001;420(2-3):113-7.
-
2001: Kaur G; Kulkarni S K
Subchronic studies on modulation of feeding behavior and body weight by neurosteroids in female mice.
Methods and findings in experimental and clinical pharmacology 2001;23(3):115-9.
-
2001: Kulkarni S K; Naidu P S
Animal models of tardive dyskinesia--a review.
Indian journal of physiology and pharmacology 2001;45(2):148-60.
-
2001: Raghavendra V; Kulkarni S K
Possible antioxidant mechanism in melatonin reversal of aging and chronic ethanol-induced amnesia in plus-maze and passive avoidance memory tasks.
Free radical biology & medicine 2001;30(6):595-602.
-
2001: Raghavendra V; Chopra K; Kulkarni S K
Comparative studies on the memory-enhancing actions of captopril and losartan in mice using inhibitory shock avoidance paradigm.
Neuropeptides 2001;35(1):65-9.
-
2000: Naidu P S; Kulkarni S K
Differential role of dopamine D1 and D2 receptors in isoniazid-induced vacuous chewing movements.
Methods and findings in experimental and clinical pharmacology 2000;22(10):747-51.
-
2000: Raghavendra V; Kaur G; Kulkarni S K
Anti-depressant action of melatonin in chronic forced swimming-induced behavioral despair in mice, role of peripheral benzodiazepine receptor modulation.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2000;10(6):473-81.
-
2000: Raghavendra V; Kulkarni S K
Possible mechanisms of action in melatonin reversal of morphine tolerance and dependence in mice.
European journal of pharmacology 2000;409(3):279-89.
-
2000: Kulkarni S K; Ninan I
Dopamine D4 receptors and development of newer antipsychotic drugs.
Fundamental & clinical pharmacology 2000;14(6):529-39.
-
2000: Paul V N; Chopra K; Kulkarni S K
Modulation of motor functions involving central dopaminergic system by L-histidine.
Indian journal of experimental biology 2000;38(10):988-93.
-
2000: Raghavendra V; Kulkarni S K
AT1 receptor antagonism enhances angiotensin-II-facilitated carrageenan-induced paw edema.
Methods and findings in experimental and clinical pharmacology 2000;22(8):633-6.
-
2000: Paul V N; Chopra K; Kulkarni S K
Prooxidant role of histidine in hypoxic stressed mice and Fe(3+)-induced lipid peroxidation.
Methods and findings in experimental and clinical pharmacology 2000;22(7):551-5.
-
2000: Ninan I; Kulkarni S K
Ketanserin reverses dizocilpine-suppression of morphine dependence but not tolerance in mice.
Brain research 2000;876(1-2):215-9.
-
2000: Kulkarni S K; Jain N K; Singh A
Cyclooxygenase isoenzymes and newer therapeutic potential for selective COX-2 inhibitors.
Methods and findings in experimental and clinical pharmacology 2000;22(5):291-8.
-
2000: Gupta M; Kulkarni S K
Studies on anticonvulsant actions of L-deprenyl.
Indian journal of experimental biology 2000;38(4):332-7.
-
2000: Raghavendra V; Agrewala J N; Kulkarni S K
Melatonin reversal of lipopolysacharides-induced thermal and behavioral hyperalgesia in mice.
European journal of pharmacology 2000;395(1):15-21.
-
2000: Raghavendra V; Kulkarni S K
Melatonin reversal of DOI-induced hypophagia in rats; possible mechanism by suppressing 5-HT(2A) receptor-mediated activation of HPA axis.
Brain research 2000;860(1-2):112-8.
-
2000: George B; Kulkarni S K; Mathur R
Motor and electrographic response of refractory experimental status epilepticus in rats and effect of calcium channel blockers.
Indian journal of experimental biology 2000;38(2):105-12.
-
2000: Kumar A; Jain N K; Kulkarni S K
Analgesic and anti-inflammatory effects of phosphodiesterase inhibitors.
Indian journal of experimental biology 2000;38(1):26-30.
-
1999: Jain N K; Kulkarni S K
Antinociceptive and anti-inflammatory effects of Tanacetum parthenium L. extract in mice and rats.
Journal of ethnopharmacology 1999;68(1-3):251-9.
-
1999: Ninan I; Kulkarni S K
Quinpirole, 8-OH-DPAT and ketanserin modulate catalepsy induced by high doses of atypical antipsychotics.
Methods and findings in experimental and clinical pharmacology 1999;21(9):603-8.
-
1999: Patil C S; Kulkarni S K
The morphine sparing effect of physostigmine.
Methods and findings in experimental and clinical pharmacology 1999;21(8):523-7.
-
1999: Raghavendra V; Kulkarni S K
Reversal of morphine tolerance and dependence by melatonin: possible role of central and peripheral benzodiazepine receptors.
Brain research 1999;834(1-2):178-81.
-
1999: Ninan I; Kulkarni S K
Effect of olanzapine on behavioural changes induced by FG 7142 and dizocilpine on active avoidance and plus maze tasks.
Brain research 1999;830(2):337-44.
-
1999: Raghavendra V; Agrewala J N; Kulkarni S K
Role of centrally administered melatonin and inhibitors of COX and NOS in LPS-induced hyperthermia and adipsia.
Prostaglandins, leukotrienes, and essential fatty acids 1999;60(4):249-53.
-
1999: Jain N K; Kulkarni S K
L-NAME, a nitric oxide synthase inhibitor, modulates cholinergic antinociception.
Methods and findings in experimental and clinical pharmacology 1999;21(3):161-5.
-
1999: Ninan I; Kulkarni S K
Involvement of dopamine D2 and 5-HT1A receptors in roxindole-induced antinociception.
Indian journal of experimental biology 1999;37(3):234-7.
-
1999: Ninan I; Kulkarni S K
Differential effects of olanzapine at dopamine D1 and D2 receptors in dopamine depleted animals.
Psychopharmacology 1999;142(2):175-81.
-
1999: Ninan I; Kulkarni S K
Preferential inhibition of dizocilpine-induced hyperlocomotion by olanzapine.
European journal of pharmacology 1999;368(1):1-7.
-
1999: Reddy D S; Kulkarni S K
Sex and estrous cycle-dependent changes in neurosteroid and benzodiazepine effects on food consumption and plus-maze learning behaviors in rats.
Pharmacology, biochemistry, and behavior 1999;62(1):53-60.
-
1999: Ninan I; Kulkarni S K
Antagonism by pimozide of olanzapine-induced hypothermia.
Fundamental & clinical pharmacology 1999;13(5):541-6.
-
1999: Raghavendra V; Chopra K; Kulkarni S K
Brain renin angiotensin system (RAS) in stress-induced analgesia and impaired retention.
Peptides 1999;20(3):335-42.
-
1998: Ninan I; Kulkarni S K
Dopamine receptor sensitive effect of dizocilpine on feeding behaviour.
Brain research 1998;812(1-2):157-63.
-
1998: Jain N K; Kulkarni S K
Antinociceptive effect of sumatriptan in mice.
Indian journal of experimental biology 1998;36(10):973-9.
-
1998: Raghavendra V; Chopra K; Kulkarni S K
Involvement of cholinergic system in losartan-induced facilitation of spatial and short-term working memory.
Neuropeptides 1998;32(5):417-21.
-
1998: Ninan I; Kulkarni S K
5-HT2A receptor antagonists block MK-801-induced stereotypy and hyperlocomotion.
European journal of pharmacology 1998;358(2):111-6.
-
1998: Reddy D S; Kaur G; Kulkarni S K
Sigma (sigma1) receptor mediated anti-depressant-like effects of neurosteroids in the Porsolt forced swim test.
Neuroreport 1998;9(13):3069-73.
-
1998: Kulkarni S K; Joseph P
Anticonvulsant profile of Siotone granules, a herbal preparation.
Indian journal of experimental biology 1998;36(7):658-62.
-
1998: Ninan I; Kulkarni S K
Preferential blockade by clozapine of hyperlocomotion induced by non-competitive NMDA antagonist MK-801.
Indian journal of physiology and pharmacology 1998;42(3):375-82.
-
1998: George B; Mathur R; Kulkarni S K
Development of self-sustaining limbic status epilepticus by continuous ventral hippocampal stimulation followed by low dose pilocarpine in rats.
Indian journal of physiology and pharmacology 1998;42(3):359-68.
-
1998: Reddy D S; Kulkarni S K
Possible role of nitric oxide in the nootropic and antiamnesic effects of neurosteroids on aging- and dizocilpine-induced learning impairment.
Brain research 1998;799(2):215-29.
-
1998: Raghavendra V; Chopra K; Kulkarni S K
Modulation of motor functions involving the dopaminergic system by AT1 receptor antagonist, losartan.
Neuropeptides 1998;32(3):275-80.
-
1998: George B; Kulkarni S K
Protective effect of clozapine against pentylenetetrazol convulsions and kindling.
Methods and findings in experimental and clinical pharmacology 1998;20(5):395-401.
-
1998: Reddy D S; Kulkarni S K
The role of GABA-A and mitochondrial diazepam-binding inhibitor receptors on the effects of neurosteroids on food intake in mice.
Psychopharmacology 1998;137(4):391-400.
-
1998: Reddy D S; Kulkarni S K
Inhibition of neuronal nitric oxide synthase (n-cNOS) reverses the corticotrophin-induced behavioral effects in rats.
Molecular and cellular biochemistry 1998;183(1-2):25-38.
-
1998: Shaji A V; Kulkarni S K
Evidence of GABAergic modulation in melatonin-induced short-term memory deficits and food consumption.
Methods and findings in experimental and clinical pharmacology 1998;20(4):311-9.
-
1998: Kulkarni S K; Shaji A V
Behavioral pharmacology of melatonin.
Methods and findings in experimental and clinical pharmacology 1998;20(3):237-47.
-
1998: Reddy D S; Kulkarni S K
The effects of neurosteroids on acquisition and retention of a modified passive-avoidance learning task in mice.
Brain research 1998;791(1-2):108-16.
-
1998: Shaji A V; Kulkarni S K
Central nervous system depressant activities of melatonin in rats and mice.
Indian journal of experimental biology 1998;36(3):257-63.
-
1998: Reddy D S; Kulkarni S K
Proconvulsant effects of neurosteroids pregnenolone sulfate and dehydroepiandrosterone sulfate in mice.
European journal of pharmacology 1998;345(1):55-9.
-
1998: Ninan I; Kulkarni S K
Partial agonistic action of clozapine at dopamine D2 receptors in dopamine depleted animals.
Psychopharmacology 1998;135(3):311-7.
-
1997: Reddy D S; Kulkarni S K
Reversal of benzodiazepine inverse agonist FG 7142-induced anxiety syndrome by neurosteroids in mice.
Methods and findings in experimental and clinical pharmacology 1997;19(10):665-81.
-
1997: Reddy D S; Kulkarni S K
Chronic neurosteroid treatment prevents the development of morphine tolerance and attenuates abstinence behavior in mice.
European journal of pharmacology 1997;337(1):19-25.
-
1997: George B; Kulkarni S K
Dopaminergic modulation of lithium/pilocarpine-induced status epilepticus in rats.
Methods and findings in experimental and clinical pharmacology 1997;19(7):481-8.
-
1997: Kulkarni S K; Ninan I
Inhibition of morphine tolerance and dependence by Withania somnifera in mice.
Journal of ethnopharmacology 1997;57(3):213-7.
-
1997: Reddy D S; Kulkarni S K
Neurosteroid coadministration prevents development of tolerance and augments recovery from benzodiazepine withdrawal anxiety and hyperactivity in mice.
Methods and findings in experimental and clinical pharmacology 1997;19(6):395-405.
-
1997: George B; Kulkarni S K
Modulation of lithium-pilocarpine-induced status epilepticus by adenosinergic agents.
Methods and findings in experimental and clinical pharmacology 1997;19(5):329-33.
-
1997: Roychoudhury M; Kulkarni S K
Antianxiety profile of ondansetron, a selective 5-HT3 antagonist, in a novel animal model.
Methods and findings in experimental and clinical pharmacology 1997;19(2):107-11.
-
1997: Reddy D S; Kulkarni S K
Differential anxiolytic effects of neurosteroids in the mirrored chamber behavior test in mice.
Brain research 1997;752(1-2):61-71.
-
1997: Roychoudhury M; Kulkarni S K
Effects of ondansetron on short-term memory retrieval in mice.
Methods and findings in experimental and clinical pharmacology 1997;19(1):43-6.
-
1996: Roychoudhury M; Kulkarni S K
Prevention of morphine discontinuation phenomenon in mice by ondansetron, a selective 5-HT3 antagonist.
Methods and findings in experimental and clinical pharmacology 1996;18(10):677-83.
-
1996: Kulkarni S K; Goel R K
Gastric antiulcer activity of UL-409 in rats.
Indian journal of experimental biology 1996;34(7):683-8.
-
1996: Ninan I; Kulkarni S K
Clozapine-induced cognitive dysfunction in mice.
Methods and findings in experimental and clinical pharmacology 1996;18(6):367-72.
-
1996: George B; Kulkarni S K
Protective effects of GABAergic drugs and other anticonvulsants in lithium-pilocarpine-induced status epilepticus.
Methods and findings in experimental and clinical pharmacology 1996;18(5):335-40.
-
1996: Kulkarni S K; Reddy D S
Animal behavioral models for testing antianxiety agents.
Methods and findings in experimental and clinical pharmacology 1996;18(3):219-30.
-
1995: Kulkarni S K; George B
Lithium-pilocarpine neurotoxicity: a potential model of status epilepticus.
Methods and findings in experimental and clinical pharmacology 1995;17(8):551-67.
-
1995: Verma A; Kulkarni S K
N-Methyl-D-aspartate receptor participation in Parkinson's disease, a neurodegenerative disorder.
Annals of the New York Academy of Sciences 1995;765():327.
-
1995: Kulkarni S K; George B
Pentylenetetrazol-induced kindling in animals: protective effect of BR-16A.
Indian journal of experimental biology 1995;33(6):424-7.
-
1995: Verma A; Kulkarni S K
Role of D1/D2 dopamine and N-methyl-D-aspartate (NMDA) receptors in morphine tolerance and dependence in mice.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1995;5(2):81-7.
-
1994: Kulkarni S K; Sharma A
Reversal of diazepam withdrawal induced hyperactivity in mice by BR 16-A (Mentat), a herbal preparation.
Indian journal of experimental biology 1994;32(12):886-8.
-
1994: Kulkarni S K; George B
Kindling model of epilepsy.
Methods and findings in experimental and clinical pharmacology 1994;16(10):735-45.
-
1994: Kulkarni S K; Sharma A
Rat anococcygeus: a dynamic smooth muscle preparation for experimental pharmacology.
Methods and findings in experimental and clinical pharmacology 1994;16(6):379-85.
-
1994: Sharma A; Kulkarni S K
On the characterization of dopamine-induced contractile response of rat anococcygeus muscle preparation.
Indian journal of experimental biology 1994;32(3):176-9.
-
1994: Sharma A; Kulkarni S K
Dopamine receptor mediated antidepressant action of B-HT 920 in mice.
Indian journal of experimental biology 1994;32(3):172-5.
-
1993: Kulkarni S K; Sharma K
Alprazolam modifies animal behaviour on elevated plus-maze.
Indian journal of experimental biology 1993;31(11):908-11.
-
1993: Verma A; Kulkarni S K; Nayar U
Effect of D1- and D2-dopamine agonists on neocortical and hippocampal EEG activity of rat brain: modulation of rimcazole effect.
Methods and findings in experimental and clinical pharmacology 1993;15(8):515-25.
-
1993: Verma A; Kulkarni S K
Differential role of dopamine receptor subtypes in thermoregulation and stereotypic behavior in naive and reserpinized rats.
Archives internationales de pharmacodynamie et de thérapie 1993;324():17-32.
-
1993: Kulkarni S K; Verma A
Protective effect of BR-16A (Mentat), a herbal preparation on alcohol abstinence-induced anxiety and convulsions.
Indian journal of experimental biology 1993;31(5):435-9.
-
1993: Sharma A C; Kulkarni S K
(+/-)Baclofen sensitive scopolamine-induced short-term memory deficits in mice.
Indian journal of experimental biology 1993;31(4):348-52.
-
1993: Sharma A C; Kulkarni S K
Evidence for benzodiazepine receptor interaction with MK 801 in anxiety related behaviour in rats.
Indian journal of experimental biology 1993;31(2):191-3.
-
1992: Kulkarni S K; Verma A
Prevention of development of tolerance and dependence to opiate in mice by BR-16A (Mentat), a herbal psychotropic preparation.
Indian journal of experimental biology 1992;30(10):885-8.
-
1992: Kulkarni S K; Verma A
Evidence for nootropic effect of BR-16A (Mentat), a herbal psychotropic preparation, in mice.
Indian journal of physiology and pharmacology 1992;36(1):29-34.
-
1992: Sharma A C; Kulkarni S K
Evaluation of learning and memory mechanisms employing elevated plus-maze in rats and mice.
Progress in neuro-psychopharmacology & biological psychiatry 1992;16(1):117-25.
-
1992: Verma A; Kulkarni S K
D1/D2 dopamine and N-methyl-D-aspartate (NMDA) receptor participation in experimental catalepsy in rats.
Psychopharmacology 1992;109(4):477-83.
-
1992: Verma A; Kulkarni S K
Modulation of MK-801 response by dopaminergic agents in mice.
Psychopharmacology 1992;107(2-3):431-6.
-
1991: Verma A; Kulkarni S K
Effect of a herbal psychotropic preparation, BR-16A (Mentat), on performance of mice on elevated plus-maze.
Indian journal of experimental biology 1991;29(12):1120-3.
-
1991: Aley K O; Kulkarni S K
Baclofen analgesia in mice: a GABAB-mediated response.
Methods and findings in experimental and clinical pharmacology 1991;13(10):681-6.
-
1991: Verma A; Kulkarni S K
Chronic electroconvulsive shock alters hypothermic response of B-HT 920 and SKF 38393 in rats.
The Journal of pharmacy and pharmacology 1991;43(11):813-4.
-
1991: Kulkarni S K; Sharma A C
Elevated plus-maze: a novel psychobehavioral tool to measure anxiety in rodents.
Methods and findings in experimental and clinical pharmacology 1991;13(8):573-7.
-
1991: Sharma A C; Kulkarni S K; Nayar U
Effect of NMDA-receptor ligands on neocortical and hippocampal EEG activity of rat brain.
Indian journal of experimental biology 1991;29(8):744-50.
-
1991: Thorat S N; Kulkarni S K
Antagonism of caffeine-induced convulsions by ethanol and dizocilpine (MK-801) in mice.
Methods and findings in experimental and clinical pharmacology 1991;13(6):413-7.
-
1991: Gautam S K; Kulkarni S K
GABA/BZ-and NMDA-receptor interaction in digoxin-induced convulsions in rats.
Indian journal of experimental biology 1991;29(7):636-40.
-
1991: Verma A; Kulkarni S K
Dopamine receptor mediated hypothermic action of B-HT 920 in rats.
The Journal of pharmacy and pharmacology 1991;43(6):421-4.
-
1991: Sharma A C; Thorat S N; Nayar U; Kulkarni S K
Dizocilpine, ketamine and ethanol reverse NMDA-induced EEG changes and convulsions in rats and mice.
Indian journal of physiology and pharmacology 1991;35(2):111-6.
-
1991: Sharma A C; Kulkarni S K
Effects of MK-801 and ketamine on short-term memory deficits in passive avoidance step-down task paradigm in mice.
Methods and findings in experimental and clinical pharmacology 1991;13(3):155-9.
-
1991: Aley K O; Kulkarni S K
Altered response to GABAergic agents following electro and chemo convulsions in mice.
Indian journal of experimental biology 1991;29(3):241-3.
-
1991: Verma A; Kulkarni S K
Concomitant D1 dopamine receptor activation (SKF 38393) unmasks D2 dopaminergic actions of B-HT 920 in mice.
Indian journal of experimental biology 1991;29(2):123-6.
-
1991: Verma A; Kulkarni S K
Alpha 2-adrenoceptor- and D2-dopamine receptor-mediated analgesic response of B-HT 920.
The Journal of pharmacy and pharmacology 1991;43(2):131-3.
-
1990: Thorat S N; Kulkarni S K
Benzodiazepine inverse agonist, DMCM- and peripheral agonist, Ro 5-4864-induced convulsions in mice: effect of adenosinergic agents.
Indian journal of experimental biology 1990;28(12):1160-5.
-
1990: Aley K O; Kulkarni S K; Mathur R; Nayar U
Effect of chronic treatment of Ro 15-1788 and its withdrawal on cortical and hippocampal EEG activity in rats.
Indian journal of experimental biology 1990;28(12):1149-59.
-
1990: Thorat S N; Kulkarni S K
Effect of MK-801 and its interaction with adenosinergic agents and carbamazepine against hypoxic stress-induced convulsions and death in mice.
Methods and findings in experimental and clinical pharmacology 1990;12(9):595-600.
-
1990: Aley K O; Kulkarni S K
Effect of baclofen, a GABAB-agonist, on forced swimming-induced immobility in mice.
Archives internationales de pharmacodynamie et de thérapie 1990;307():18-31.
-
1990: Sharma A C; Kulkarni S K
Evidence for GABA-BZ receptor modulation in short-term memory passive avoidance task paradigm in mice.
Methods and findings in experimental and clinical pharmacology 1990;12(3):175-80.
-
1990: Kulkarni S K; Chopra K
The dopaminergic actions of B-HT 920.
Methods and findings in experimental and clinical pharmacology 1990;12(2):99-102.
-
1990: Thorat S N; Kulkarni S K
The protective effect of adenosinergic agents, Ro 5-4864 and carbamazepine against hypoxic stress-induced neurotoxicity in mice.
Methods and findings in experimental and clinical pharmacology 1990;12(1):17-22.
-
1989: Aley K O; Kulkarni S K
GABAergic agents-induced antinociceptive effect in mice.
Methods and findings in experimental and clinical pharmacology 1989;11(10):597-601.
-
1989: Aley K O; Kulkarni S K
GABAergic agents and clonidine attenuate footshock-induced aggression in mice.
Methods and findings in experimental and clinical pharmacology 1989;11(9):541-5.
-
1989: Shukla V K; Sethi A K; Garg S K; Ganguly N K; Kulkarni S K
Effect of venoruton on hypoxic stress-induced neurotoxicity in mice and oxygen free radical generation by human neutrophils.
Archives internationales de pharmacodynamie et de thérapie 1989;299():127-33.
-
1989: Aley K O; Kulkarni S K
GABA-mediated modification of despair behavior in mice.
Naunyn-Schmiedeberg's archives of pharmacology 1989;339(3):306-11.
-
1988: Aley K O; Kulkarni S K
Studies on the neuropsychopharmacological profile of fengabine (SL 79229) in mice.
Methods and findings in experimental and clinical pharmacology 1988;10(9):563-8.
-
1988: Chopra K; Kulkarni S K
Potentiation of dopamine receptor-mediated responses by B-HT 920 in mice.
Archives internationales de pharmacodynamie et de thérapie 1988;294():46-55.
-
1988: Chopra K; Kunchandy J; Kulkarni S K
Benzodiazepine inverse agonist FG-7142-induced delayed behavioral depression in mice.
Archives internationales de pharmacodynamie et de thérapie 1988;294():56-63.
-
1988: Aley K O; Kulkarni S K
Anticatatonic effect of venoruton.
Methods and findings in experimental and clinical pharmacology 1988;10(4):263-5.
-
1988: Kunchandy J; Kulkarni S K
Hypoxic stress-induced convulsion and death: protective effect of alpha 2-adrenoceptor and benzodiazepine receptor agonists and Ro 5-4864.
Archives internationales de pharmacodynamie et de thérapie 1988;292():35-44.
-
1988: Thorat S N; Kulkarni S K
Involvement of postsynaptic adrenergic mechanism(s) in the ATP-contractions of the rat anococcygeus muscle and the effect of extracellular Ca2+.
Archives internationales de pharmacodynamie et de thérapie 1988;291():104-12.
-
1987: Aley K O; Kulkarni S K
Studies on meperidine-induced catalepsy in mice.
Methods and findings in experimental and clinical pharmacology 1987;9(8):493-6.
Sign-in to see more
